Home   >  
Others Pathway
  >  
TLR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

TLR

Chemical Structure Cat. No. Product Name CAS No.
Pam3CSK4 TFA Chemical Structure
 BCP48883 Pam3CSK4 TFA 112208-01-2
Pam3CSK4 TFA is a toll-like receptor 1/2 (TLR1/2) agonist with an EC50 of 0.47 ng/mL for human TLR1/2.
Enpatoran hydrochloride Chemical Structure
 BCP48403 Enpatoran hydrochloride 2101945-93-9
Enpatoran Hydrochloride is a potent and orally active inhibitor of TLR7/8, with IC50s of 11.1 nM and 24.1 nM in HEK293 cells.
TLR7/8-IN-1 Chemical Structure
 BCP48001 TLR7/8-IN-1 2205095-75-4
TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b.
Sparstolonin B Chemical Structure
 BCP44673 Sparstolonin B 1259330-61-4
Sparstolonin B is a potent TLR2 and TLR4 antagonist, exhibiting anti-inflammatory and anti-viral (anti-HIV) properties.
Afimetoran Chemical Structure
 BCP44088 Afimetoran 2171019-55-7
Afimetoran is a toll-like receptor antagonist and immunomodulator.
Imiquimod hydrochloride Chemical Structure
 BCP42840 Imiquimod hydrochloride 99011-78-6
Imiquimod hydrochloride, an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist.
Glycopyranoside lipid A Chemical Structure
 BCP39685 Glycopyranoside lipid A 1246298-63-4
Monophosphoryl Lipid A is a toll-like receptor 4 agonist with potential immunostimulatory activity, which is commonly used as a vaccine adjuvant.
Resiquimod HCl Chemical Structure
 BCP38086 Resiquimod HCl 1313757-36-6
Resiquimod is an imidazoquinolinamine and Toll-like receptor (TLR) agonist with potential immune response modifying activity.
Pam3CSK4 Chemical Structure
 BCP35467 Pam3CSK4 112208-00-1
Pam3CSK4 is a toll-like receptor 1/2 (TLR1/2) agonist with an EC50 of 0.47 ng/mL for human TLR1/2.
Selgantolimod Chemical Structure
 BCP35099 Selgantolimod 2004677-13-6
Selgantolimod is an orally active, potent and selective toll-like receptor 8 (TLR8) agonist for the treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infection.
123下一页末页共 46 条记录 1 / 5 页 
0086-13720134139